Georgia: DR-TB patients find hope in new treatments
Multidrug-resistant tuberculosis (MDR-TB) is a major public health issue in Georgia: 12 per cent of all new patients and 39 per cent of those who have previously been treated for TB have a multidrug-resistant form of the disease.

In 2016, over 150 patients in Georgia were receiving bedaquiline or delamanid as part of an improved treatment regimen for multidrug-resistant tuberculosis (MDR-TB) – the highest number supported by us in any country.

Approximately 10 per cent of MDR-TB patients have extensively drug-resistant TB (XDR-TB). Current treatment outcomes for these patients are poor, notably because of the length, complexity and toxicity of existing regimens.

We started supporting the Ministry of Health in the implementation of the new drugs in 2014.

 
Georgia: DR-TB patients find hope in new treatments
Georgia

endTB partnership launches clinical trial to target toughest strains of tuberculosis

Statement 6 Mar 2017
 
MSF TB Treatment in Mumbai, India
Photo Story

"Providing comprehensive treatment for patients with tuberculosis"

25 Oct 2016
Photo Story
 
Georgia

Drug resistant-TB patients cured after two years of treatment

Project Update 6 Feb 2009
 
Georgia

Georgia - two months on, uncertainty remains for many

Project Update 13 Oct 2008
 
Georgia

A day assisting displaced people in Tbilisi

Project Update 29 Aug 2008
 
Georgia

Tbilisi a haven for displaced people

Project Update 28 Aug 2008
 
Georgia

MSF medical team has visited Tskhinvali hospital, South Ossetia

Project Update 27 Aug 2008
 
Georgia

MSF continues seeking access to South Ossetia while assisting people displaced by the conflict

Project Update 21 Aug 2008
 
Georgia

MSF teams in Georgia and region: concerns about interrupted TB treatment

Project Update 12 Aug 2008
 
Georgia

Home-care for patients suffering from multiple drug-resistant tuberculosis

Project Update 25 Mar 2008
 
Georgia

An MDR-TB patient in Georgia ...

Project Update 25 Mar 2008
 
Georgia

TB care in Georgia

Project Update 24 Mar 2008